Karyopharm Therapeutics Inc (NASDAQ:KPTI)

19.75
Delayed Data
As of May 18
 +0.67 / +3.51%
Today’s Change
7.48
Today|||52-Week Range
20.39
+105.73%
Year-to-Date

Today’s Trading

Previous close19.08
Today’s open19.15
Day’s range19.11 - 20.39
Volume903,585
Average volume (3 months)628,718
Market cap$1.1B
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)+3.77%
Earnings growth (this year)-13.10%
Earnings growth (next 5 years)-49.42%
Revenue growth (last year)+942.21%
P/E ratioNM
Price/Sales274.54
Price/Book6.96

Competitors

 Today’s
change
Today’s
% change
ASMBAssembly Biosciences...-0.71-1.67%
CMTAClementia Pharmaceut...+0.08+0.44%
ZEALZealand Pharma A/S+0.38+2.41%
ABEOAbeona Therapeutics ...-2.57-12.00%
Data as of 4:00pm ET, 05/18/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.73
Annual revenue (last year)$1.6M
Annual profit (last year)-$129.0M
Net profit margin-8,036.39%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael G. Kauffman
President &
Chief Scientific Officer
Sharon Shacham
Corporate headquarters
Newton, Massachusetts

Forecasts